Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Increases By 324.2%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totaling 2,265 shares, an increase of 324.2% from the June 15th total of 534 shares. Based on an average daily trading volume, of 7,256 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the shares of the stock are short sold.

Fidelity Disruptive Medicine ETF Stock Down 1.8%

FMED stock traded down $0.54 on Friday, reaching $29.56. 9,105 shares of the company’s stock were exchanged, compared to its average volume of 12,366. The stock has a fifty day moving average of $26.04 and a 200-day moving average of $26.00. Fidelity Disruptive Medicine ETF has a twelve month low of $22.80 and a twelve month high of $30.33. The firm has a market cap of $47.30 million, a PE ratio of 41.33 and a beta of 0.74.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

Several institutional investors have recently made changes to their positions in FMED. Jane Street Group LLC boosted its holdings in Fidelity Disruptive Medicine ETF by 95.4% during the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock worth $2,473,000 after buying an additional 44,630 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Fidelity Disruptive Medicine ETF by 4.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after purchasing an additional 31,629 shares during the last quarter. BXM Wealth LLC purchased a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter worth $243,000. Vise Technologies Inc. purchased a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter worth $234,000. Finally, Virtu Financial LLC acquired a new stake in Fidelity Disruptive Medicine ETF in the fourth quarter valued at $228,000.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.